Spironolactone in chronic hemodialysis patients improves cardiac function.

Abstract

We performed this study to assess whether low dose spironolactone could be administered in hemodialysis (HD) patients with moderate to severe heart failure to improve cardiovascular function and reduce hospitalization without inducing hyperkalemia. We enrolled 16 chronic HD patients with moderate to severe heart failure and left ventricle ejection fraction… (More)

Topics

  • Presentations referencing similar topics